Send the following on WhatsApp
Continue to ChatImpact of eculizumab on hospitalization rates and relapse treatment in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from the phase 3 PREVENT study - https://avesis.omu.edu.tr/yayin/83edb199-5200-4856-b6a2-1b456be72741/impact-of-eculizumab-on-hospitalization-rates-and-relapse-treatment-in-patients-with-aquaporin-4-antibody-positive-neuromyelitis-optica-spectrum-disorder-findings-from-the-phase-3-prevent-study